What the study says
Plain-English summary
The repeated-measures analysis included 330 older adults with ten urinary phthalate metabolites measured in 2019, 2021 and 2023; a separate 2023 cross-sectional analysis included 1,020 participants.
The indexed abstract reported a plasma NfL association for the 2021 mixture and the joint three-wave mixture, while the smaller repeated-measures cognitive sample had no significant MMSE association.
The study measured a plasma NfL biomarker but did not use it by itself to diagnose dementia, identify an individual's prognosis, or test whether replacing a household product protects cognition.
Why it matters
Context
Repeated biomonitoring can describe measurements across survey dates without identifying a product source, establishing a complete long-term dose, or proving that one sampling design is universally superior.
What it cannot prove
Limitations
The full methods and supplement were unavailable. The study was observational, the larger cognitive analysis was cross-sectional, and the findings may be affected by reverse causation or residual confounding. This brief assigns no uncited biological or diagnostic meaning to plasma NfL, and it does not support causal, product-source, intervention, prevention, or individual-prognosis claims.
Proportionate next steps
Practical actions
- Keep the 330-person repeated-measures and 1,020-person cross-sectional analyses separate.
- Read the selected plasma NfL associations beside the repeated-sample MMSE null.
- Do not use the measurements to diagnose an individual, identify a product source, or claim that a product change prevents cognitive decline.
Reader question
What can three survey dates show—and what can they not prove?
The study reported selected associations between urinary phthalate mixtures and a plasma NfL biomarker. It did not prove causation, and the smaller repeated-measures group had no significant MMSE association.
What did the new study observe?
Among 330 older adults with urine measurements in 2019, 2021 and 2023, the indexed abstract reports that selected phthalate-mixture measures were associated with higher plasma NfL. It found no significant MMSE associations in the smaller repeated-measures cognitive sample. A separate 1,020-participant 2023 analysis reported selected cognitive-score associations.
Does a higher plasma NfL value diagnose dementia?
The study measured plasma NfL as a biomarker; it did not use that measurement by itself to establish a dementia diagnosis or an individual's prognosis.
Do three urine collections identify the source or complete long-term dose?
No. Measurements on three survey dates do not identify a specific product or route, and the abstract does not establish a complete exposure history between surveys.
What practical conclusion is proportionate?
The study supports further prospective research. It does not show that replacing a named product prevents cognitive decline, and it should not be used to diagnose or predict an individual's condition.
Read it yourself
Original source
Urinary phthalate exposure in relation to plasma neurofilament light chain and cognitive function among older adults: Repeated-measures and cross-sectional analyses
DOI: 10.1016/j.ecoenv.2026.120941
Open the paper or record →
